Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2017 Oct 13;924:437-450. doi: 10.1124/mol.117.108886.
Show Gene links
Show Anatomy links
Molecular Basis of Altered hERG1 Channel Gating Induced by Ginsenoside Rg3.
Gardner A, Wu W, Thomson S, Zangerl-Plessl EM, Stary-Weinzinger A, Sanguinetti MC.
???displayArticle.abstract???
Outward current conducted by human ether-à-go-go-related gene type 1 (hERG1) channels is a major determinant of action potential repolarization in the human ventricle. Ginsenoside 20(S)-Rg3 [Rg3; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol], an alkaloid isolated from the root of Panax ginseng, slows the rate of hERG1 deactivation, induces channels to open at more negative potentials than normal, and increases current magnitude. The onset of Rg3 action is extremely fast, suggesting that it binds to an extracellular accessible site on the channel to alter its gating. Here we used a scanning mutagenesis approach to identify residues in the extracellular loops and transmembrane segments of hERG1 that might interact with Rg3. Single or multiple residues of hERG1 were mutated to Ala or Cys and the resulting mutant channels were heterologously expressed in Xenopus oocytes. The effects of Rg3 on the voltage dependence of activation and the deactivation rate of mutant channel currents were characterized using the two-microelectrode voltage clamp technique. Mutation to Ala of specific residues in the S1 (Tyr420), S2 (Leu452, Phe463), and S4 (Ile521, Lys525) segments partially inhibited the effects of Rg3 on hERG1. The double mutant Y420A/L452A nearly eliminated the effects of Rg3 on voltage-dependent channel gating but did not prevent the increase in current magnitude. These findings together with molecular modeling suggest that Rg3 alters the gating of hERG1 channels by interacting with and stabilizing the voltage sensor domain in an activated state.
Ahn,
Antinociceptive Effects of Ginsenoside Rg3 in a Rat Model of Incisional Pain.
2016, Pubmed
Ahn,
Antinociceptive Effects of Ginsenoside Rg3 in a Rat Model of Incisional Pain.
2016,
Pubmed Ahuja,
Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist.
2015,
Pubmed Choi,
Ginsenoside Rg3 activates human KCNQ1 K+ channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit.
2010,
Pubmed
,
Xenbase Choi,
Ginsenoside Rg(3) decelerates hERG K(+) channel deactivation through Ser631 residue interaction.
2011,
Pubmed
,
Xenbase Choi,
Ginsenoside Rg3 enhances large conductance Ca2+-activated potassium channel currents: a role of Tyr360 residue.
2011,
Pubmed
,
Xenbase Choi,
Mutations Leu427, Asn428, and Leu431 residues within transmembrane domain-I-segment 6 attenuate ginsenoside-mediated L-type Ca(2+) channel current inhibitions.
2009,
Pubmed
,
Xenbase Fernandez,
Molecular mapping of a site for Cd2+-induced modification of human ether-à-go-go-related gene (hERG) channel activation.
2005,
Pubmed
,
Xenbase Ficker,
Molecular determinants of dofetilide block of HERG K+ channels.
1998,
Pubmed
,
Xenbase Gaita,
Short QT Syndrome: a familial cause of sudden death.
2003,
Pubmed Garg,
Molecular determinants for activation of human ether-à-go-go-related gene 1 potassium channels by 3-nitro-n-(4-phenoxyphenyl) benzamide.
2011,
Pubmed
,
Xenbase Garg,
Tuning of EAG K(+) channel inactivation: molecular determinants of amplification by mutations and a small molecule.
2012,
Pubmed
,
Xenbase Gerlach,
Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574).
2010,
Pubmed Guo,
Structure driven design of novel human ether-a-go-go-related-gene channel (hERG1) activators.
2014,
Pubmed Hornak,
Comparison of multiple Amber force fields and development of improved protein backbone parameters.
2006,
Pubmed Jeong,
Stereospecificity of ginsenoside Rg3 action on ion channels.
2004,
Pubmed
,
Xenbase Jones,
Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation.
1995,
Pubmed Kang,
Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
2005,
Pubmed Martí-Renom,
Comparative protein structure modeling of genes and genomes.
2000,
Pubmed Nah,
Ginseng ginsenoside pharmacology in the nervous system: involvement in the regulation of ion channels and receptors.
2014,
Pubmed Padilla,
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
2009,
Pubmed Pearlstein,
Contributions of the membrane dipole potential to the function of voltage-gated cation channels and modulation by small molecule potentiators.
2017,
Pubmed Perry,
PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K+ conductance.
2009,
Pubmed
,
Xenbase Perry,
Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.
2007,
Pubmed
,
Xenbase Sanguinetti,
HERG1 channel agonists and cardiac arrhythmia.
2014,
Pubmed Schreibmayer,
Voltage clamping of Xenopus laevis oocytes utilizing agarose-cushion electrodes.
1994,
Pubmed
,
Xenbase Shah,
Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.
2010,
Pubmed Smith,
The inward rectification mechanism of the HERG cardiac potassium channel.
1996,
Pubmed Stühmer,
Electrophysiological recording from Xenopus oocytes.
1992,
Pubmed
,
Xenbase Tao,
A gating charge transfer center in voltage sensors.
2010,
Pubmed
,
Xenbase Wang,
Cryo-EM Structure of the Open Human Ether-à-go-go-Related K+ Channel hERG.
2017,
Pubmed Weber,
Cancer stem cells and the impact of Chinese herbs, isolates and other complementary medical botanicals: a review.
2012,
Pubmed Whicher,
Structure of the voltage-gated K⁺ channel Eag1 reveals an alternative voltage sensing mechanism.
2016,
Pubmed Wu,
Ginsenoside Rg3, a Gating Modifier of EAG Family K+ Channels.
2016,
Pubmed
,
Xenbase Wu,
Stoichiometry of altered hERG1 channel gating by small molecule activators.
2014,
Pubmed
,
Xenbase Wu,
Concatenated hERG1 tetramers reveal stoichiometry of altered channel gating by RPR-260243.
2015,
Pubmed
,
Xenbase Wu,
Molecular Basis of Cardiac Delayed Rectifier Potassium Channel Function and Pharmacology.
2016,
Pubmed Xu,
Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243).
2008,
Pubmed
,
Xenbase Zeng,
Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator.
2006,
Pubmed Zhang,
Interactions between charged residues in the transmembrane segments of the voltage-sensing domain in the hERG channel.
2005,
Pubmed
,
Xenbase Zhou,
Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity.
2005,
Pubmed
